The Concise Manual of Apheresis Therapy

ISBN-13: 9784431544111 / Angielski / Miękka / 2013 / 418 str.

Eisei Noiri; Norio Hanafusa

Opis

This pocket-sized manualserves as a concise and ideal reference work for therapeutic approaches using apheresis, Covering both basic theory and clinical detailsto facilitate improved treatment and patient outcomes, the text considers a variety of diseases, including myasthenia gravis, multiple sclerosis, Guillain-Barre syndrome, chronic inflammatory demyelinating polyneuropathy, nephrotic syndrome, TTP/TMA, dilated cardiomyopathy, and many other conditions. The books also reviews thegrowing trend towards adoptingthis unique therapy for a wide range of health management issues such as morbid obesity and/or type 2 diabetes, and for lowering LDL-cholesterol (cholesterol apheresis) in patients unresponsive to medication or lifestyle modification."

Spis treści

Part 1. Principles and Technologies.- Chapter 1. Theoretical background of Apheresis Therapy - Norio Hanafusa.- Chapter 2. Methods to Remove Pathogens - Tamami Tanaka.- Chapter 3. Decision to Prescribe PE, DFPP, or PA- Rei Isshiki.- Chapter 4. Plasma Exchange - Daisuke Katagiri.- Chapter 5. Double Filtration Plasmapheresis - Daisuke Katagri.- Chapter 6. Plasma Adsorption- Yasuyuki Watanabe.- Chapter 7. Cryofiltration - Daisuke Katagiri.- Chapter 8. Double Filtration Plasmapheresis Thermo-mode (DF Thermo)- Mizuki Yamano.- Chapter 9. Plasma Diafiltration - Hajime Nakae.- Chapter 10. Direct Plasma Adsorption - Mayumi Miwa.- Chapter 11. Cytapheresis - Yuki Itoh.- Chapter 12. Cell-free and Concentrated Ascites Reinfusion Therapy - Norio Hanafusa.- Part 2. Therapeutic Details.- Chapter 13. Choice of Apheresis Therapy- Eisei Noiri.- Chapter 14. Determination of Dosage and Frequency of Therapy- Norio Hanafusa.- Chapter 15. Vascular Access- Koji Okamoto.- Chapter 16. Anticoagulants - Tetsushi Yamashita.- Part 3. Complications.- Chapter 17. Hypotension - Tsuyoshi Inoue.- Chapter 18. Bleeding Complications and Reduction of Coagulation Factors- Norio Hanafusa.- Chapter 19. Allergies - Motonobu Nakamura.- Chapter 20. Electrolytes Disorders - Motonobu Nakamura.- Chapter 21. Avoiding Complications during Apheresis - Tetsushi Yamashita.- Chapter 22. Infections - Osamu Yamazaki.- Part 4. Autoimmune Disorders.- Chapter 23. Neurological Diseases- Masao Iwagami.- Chapter 24. Dermatological Disorders- Masao Iwagami.- Chapter 25. Kidney Diseases- Masao Iwagami.- Chapter 26. Rheumatoid Arthritis and Collagen Diseases - Hiroko Kanda.- Chapter 27. Blood type incompatible pregnancies - Norio Hanafusa.- Chapter 28. Multiple Myeloma - Tsuyoshi Inoue.- Chapter 29. Dilated Cardiomyopathy - Yoshifumi Hamasaki.- Part 5. Pathogens with Large Molecular Weight.- Chapter 30. Low Density Lipoprotein Apheresis - Kenjiro Honda.- Chapter 31. Endotoxin Adsorption Therapy - Kent Doi.- Part 6. Diseases Necessary to Supply Coagulation Factors.- Chapter 32. Liver Diseases - Kent Doi.- Chapter 33. Thrombotic Thrombocytopenic Purpura and Thrombotic Microangiopathy - Kenjiro Honda.- Chapter 34. Inflammatory Bowel Diseases - Tsuyoshi Inoue.- Chapter 35. Hepatitis C Virus Infection - Shi Lu.- Chapter 36. Drug Intoxications - Motonobu Nakamura.- Chapter 37. Living Related Kidney Transplantation - Hiroo Kawarazaki.- Chapter 38. Peripheral Blood Stem Cell Transplantation- Naoko Watanabe-Okochi.- Part 7. Pediatric Apheresis.- Chapter 39. Apheresis in Children - Motoshi Hattori.

O autorze

Eisei Noiri, MD, PhD, FASN Department of Hemodialysis & Apheresis; Nephrology & Endocrinology, University Hospital, The University of Tokyo

Norio Hanafusa, MD, PhD. Department of Hemodialysis & Apheresis; Nephrology & Endocrinology, University Hospital, The University of Tokyo

Blurb

This pocket-sized manual serves as a concise and ideal reference work for therapeutic approaches using apheresis. Covering both basic theory and clinical details to facilitate improved treatment and patient outcomes, the text considers a variety of diseases, including myasthenia gravis, multiple sclerosis, Guillain-Barré syndrome, chronic inflammatory demyelinating polyneuropathy, nephrotic syndrome, TTP/TMA, dilated cardiomyopathy, and many other conditions. The book also reviews the growing trend toward adopting this unique therapy for a wide range of health management issues such as morbid obesity and/or type 2 diabetes, and for lowering LDL-cholesterol (cholesterol apheresis) in patients unresponsive to medication or lifestyle modification.